C M Bidwell & Associates LTD Xencor Inc Transaction History
C M Bidwell & Associates LTD
- $162 Million
- Q4 2024
A detailed history of C M Bidwell & Associates LTD transactions in Xencor Inc stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 193 shares of XNCR stock, worth $2,906. This represents 0.0% of its overall portfolio holdings.
Number of Shares
193
Previous 193
-0.0%
Holding current value
$2,906
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding XNCR
# of Institutions
199Shares Held
73.7MCall Options Held
1.7KPut Options Held
4.2K-
Black Rock Inc. New York, NY11.1MShares$167 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$135 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$121 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$92.5 Million6.6% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.04MShares$60.8 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $899M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...